Max Health Announces NZ Registration of TapClob (Clobazam) Oral Suspension

Max Health is happy to announce the approval of TapClob Oral suspension for registration for use in New Zealand, as advised by Medsafe. This is effective as of 27/02/2020 and applies to both concentrations of 5mg/mL and 10mg/mL. This product is manufactured in the UK. It is supplied to Max Health by Ethypharm UK.